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Abstract 
Introduction: The move towards evidence-based practice (EBP) requires speech-language pathologists (logopedists) to 
understand the types of studies that build an evidence base for the field as well as the standards for assessing the quality of 
evidence.  
Objectives: This article discusses the conceptual and methodological issues associated with EBP in Bulgaria, the USA, and 
Canada related to clinical stuttering intervention. This article discusses how the movement towards the current high-level 
standards of practice established in North America may challenge some of the traditional Bulgarian beliefs regarding 
stuttering treatment.  
Method: Theoretical overview and analysis of the existing literature data sources including systematic meta-analysis articles 
on EBP on stuttering. 
Results: The study outlines the steps of EBP accepted in SLP. Thirteen systematic reviews and meta-analyses are discussed 
concerning the application of research evidence to clinical decision making. These issues remain problematic for Bulgarian 
logopedists who received their training before or during the recent professional shift from a special education subspecialty to 
a health profession specialty as represented by speech-language pathology (SLP).  
Conclusions: The professional bodies that govern clinical practice in the Bulgarian health fields are not currently guided by 
EBP concepts. In Bulgaria, there is no evidence-based framework for the prevention, diagnosis, and treatment of stuttering 
as there is in the USA and Canada. In Bulgaria EBP stands as a fundamental way to promote changes appropriate for SLP 
as a health profession. 
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1. Introduction 
For Bulgarian clinicians who treat speech and lan-
guage problems, the concept of evidence-based 
practice (EBP) is a new one. The National Agency 
of Evaluation and Accreditation oversees the quali-
ty of university clinical programs at the Bachelor, 
Masters, and Ph.D. level. However, Bulgarian 
logopedists (speech-language pathologists, SLPs) 
are not yet required to demonstrate the ability to: (i) 
recognize the needs, abilities, values, preferences, 
and interests of individuals and their families to 
whom they provide clinical services; (ii) acquire 
and maintain the knowledge and skills that are 
necessary to provide high quality professional 
services, including knowledge and skills related to 
EBP; (iii) evaluate prevention, screening, 
diagnostic procedures, protocols, and measures to 
identify maximally informative and cost-effective 
diagnostic and screening tools; (iv) evaluate the 
efficacy, effectiveness, and efficiency of clinical 
protocols for prevention, treatment, and 
enhancement using criteria recognized in the EBP 
literature in the leading countries in that area 
(Georgieva, 2010). Practicing logopedists are not 
registered by the Bulgarian Health Profession 
Council and membership in the Bulgarian Society 
of Logopedists is not required. Consequently, the 
implementation of the EBP has been problematic, 
both for clinical practice and in research develop-
ment.  
The American Speech-Language-Hearing Associ-
ation (ASHA) and the Canadian Association of 
Speech-Language Pathologists and Audiologists 
(CASLPA) both have a strong tradition of EBP 
application since the early 1990s (ASHA, 2005; 
Bernstein Ratner, 2006, 2018; Dodd, 2007; Or-
likoff, Schiavetti, & Metz, 2015; Plante, 2004). The 
influence of EBP within Canadian SLP came early 
as a consequence of evidence-based medicine, 
which was largely conceptualised by epidemiolo-
gist David Sackett and his medical colleagues at 
McMaster University in Hamilton, Ontario, Cana-
da (Sackett, 1981; Sackett, Rosenberg, Gray, 
Haynes, & Richardson, 1996; Sackett, Straus, 
Richardson, Rosenberg, & Haynes, 2000; Thoma 
& Eaves, 2015). In the USA, the advent of EBP 
was spurred by affiliated advances in evidence-
based medicine as promoted by the American 
Medical Association as well as a growing focus on 
translational science among a multitude of allied 
health professions, both domestically and abroad. 
By 2006, Pietranton had already noted over 18 000 
citations of the term evidence-based in published 
articles in the professional scientific literature. Fib-
iger and his colleagues (2008, p. 7) analysed health 
and human services for persons who stutter in Bul-
garia and other East-European countries, conclud-
ing that, for adults who stutter (AWS), “efficacy 
and effectiveness measures are underdeveloped 
and resources, social support, and information are 
lacking” (Fibiger, Peters, Euler, & Neumann, 2008, 
p. 7). In the same publication, the authors further 
postulated that “Therapy outcome evaluation, 
however, seems insufficient compared with 
outcome evaluation assessment and best practice 
norms in Western countries” (p. 6). The Bulgarian 
health system does not offer evidence-based treat-
ment for patients with communication disorders, 
including AWS (Georgieva, 2005).   
With respect to stuttering, there are a limited num-
ber of publications related with EBP in Bulgaria 
(Georgieva, 2014; Georgieva, 2015a; Georgieva, 
2015b; Georgieva & Stoilova, 2018; Georgieva, 
Simonska, & Stoilova, 2018). However, the wide-
spread adoption of EBP in the USA and elsewhere 
is leading to an increase in the evidence base and a 
better understanding of which treatment approach-
es show the greatest efficacy and effectiveness 
(Bothe, 2003; Davidow, Bothe, & Bramlett, 2006; 
Finn, 2003; Irani, Gabel, Daniels, & Hughes, 2012; 
Kent, 2006; Lee & Hunsley, 2015; Lickley, 2007; 
Neumann, Euler, Bosshardt, Cook, Sandrieser, & 
Sommer, 2017; Onslow, 2003; Perez & Stoeckle, 
2016; Turkstra, Norman, Whyte, Dijkers, & Hart, 
2016).  Efficacy is the probability of benefit to indi-
viduals in a defined population from a technology 
or procedure applied for a given condition under 
ideal conditions of use, whereas effectiveness 
measures the probability of benefit to individuals in 
a defined population from a technology or proce-
dure applied for a given condition under average 
conditions of use (Pietranton, 2006, p. 50). 
Although there is no universally accepted clinical 
approach for all AWS, EBP “dictates that clinicians 
integrate the latest scientific evidence with their 
clinical expertise and the values of the family into 
the clinical decision-making process” so as to cus-
tomise acceptable, appropriate, and effective man-
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agement of stuttering for the individual client (Byrd 
& Donaher, 2018).  
It is important to remember that EBP entails more 
than merely referring to published stuttering litera-
ture, which as Blomgren and his colleagues (2005) 
note, “remains characterised by primarily ‘asser-
tion-based’ or ‘opinion-based’ treatments [that] by 
definition are based on unverified treatment tech-
niques and/or procedures.” Indeed, effective EBP 
requires a critical examination of research evidence 
to assess its strength, quality, and appropriateness 
for supporting practice decisions. 
2. Objectives of the Study 
This article discusses the conceptual and 
methodological issues associated with EBP im-
plementation in Bulgaria and the United States of 
America (USA) and Canada related to clinical 
stuttering intervention. The article discusses how 
the movement towards the current high-level 
standards of practice established by the American 
Speech-Language-Hearing Association (ASHA) 
may challenge some of the traditional Bulgarian 
beliefs regarding stuttering treatment. In particular, 
the authors discuss the differential application of 
EBP with respect to outcome and the application of 
evidence to clinical decision making in the treat-
ment of stuttering over the past decade (2009-
2019). 
3. Method 
As EBP has only recently been introduced in Bul-
garian practice, the present article serves as a theo-
retical comparative overview of the existing litera-
ture, including available systematic meta-analyses 
(SMA) of evidence-based stuttering treatment.  
Inclusion criteria:  
(i) SMAs, as a quantative approach for the 
systematic summary of results from previous re-
search studies, play a supporting role in the plan-
ning process of three Bulgarian research studies 
during the period 2009-2019. These provided evi-
dence to answer specific clinical questions, such as: 
What assessment and treatment to apply for people 
who stutter? How to plan our research studies for 
the target population – children and adults? Which 
outcomes to measure?  
(ii) Evidence was collected by means of elec-
tronic searches of stuttering articles using the Web 
of Science research database.  
In this way, we sought to avoid the traditional nar-
rative review of the thousands of articles related to 
stuttering. The application of EBP in the USA and 
Canada was used as a basis of comparison because 
EBP in the field has been highly developed in these 
countries for more than two decades.  
EBP is a decision-making process that integrates 
external scientific evidence with practitioner exper-
tise and client perspectives to improve clinical out-
comes (Dollaghan, 2007; Haynes & Johnson, 
2009; Orlikoff, Schiavetti, & Metz, 2015). The 
challenge of SLP practice and research in Bulgaria 
and USA is the matter of selecting the appropriate 
methodology for the stuttering evidence-based 
assessment and therapy. Similar to other healthcare 
specialities, the variability between individuals with 
stuttering guarantees that the process of selecting an 
appropriate research methodology will not be 
straightforward (Baxter et al., 2016; Pietranton, 
2006). 
The International Classification of Functioning, 
Disability, and Health (ICF) of the World Health 
Organization (WHO, 2001) was used in Bulgaria 
during the period 2009-2019 as the framework for 
the development of measurement tools and the 
conduct of the scientific outcome research. 
Outcomes refer to the effects attributed to a specific 
treatment or intervention. They may also be 
thought of as changes in the lives of clients and 
their environment(s) as a result of rehabilitation. 
Outcome measures are tools (e.g. instruments, 
questionnaires, scales, rating forms) that are used to 
reveal or identify client outcome. Such measures 
document change in client characteristics, 
functional abilities, or behaviours over time (see, 
for instance, Coyte, 1992; Frattali, 1998, 2013; 
Golper, 2013; Grover & Holt, 2017). 
Yaruss and Quesal (2004, 2006) adapted the ICF 
framework to the study of stuttering, with the 
explicit goal of developing a model that could be 
used to support the measurement of stuttering 
treatment outcomes. This adaptation describes how 
the stuttering can be viewed in terms of several 
interacting components like stuttering causes, 
impairment in body function, the speaker’s 
affective, behavioral, and cognitive reactions to 
disorder and impact of the disorder on the speaker’s 
quality of life. Impairment relates to the observable 
stuttering behaviors, contextual factors concern 
features such as avoidance and the effect of envi-
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ronment, while limitations or restrictions refer to 
the impact that the stuttering behaviours have on 
daily life. 
4. Results 
As there is no universally accepted definition of 
stuttering and the Bulgarian Society of Logopedists 
(BSL) has no officially accepted terminology, 
researchers from the South-West University 
(SWU, Blagoevgrad, BG) Stuttering Research 
Center adopted the following combined definition 
of stuttering: 
Disturbance in the normal fluency and time patter-
ing of speech. Primary characteristics include one 
or more of the following: (a) audible or silent 
blocking; (b) sound and syllable repetitions; (c) 
sound prolongations; (d) interjections; (e) broken 
words; (f) circumlocutions; or (g) words produced 
with an excess of tension. Associated behaviors or 
secondary characteristics include the habitual use 
of speech musculature or of other body parts 
which a stutterer uses along with the primary 
characteristics. The disturbance may be at the 
level of neuromuscular, respiratory, phonatory, or 
articulatory mechanisms. Dysfluencies are so 
numerous that they exceed the normal number or 
degree for the individual’s age, sex, or speaking 
situations (Nicolosi, Harryman, & Kresheck, 
2004, p. 295). 
This combined definition was selected because it 
“presents highly specific behavioural components 
and introduces the idea of etiology as timing dis-
turbance” (Shapiro, 2011). The definition also 
makes explicit reference “to events occurring at, 
and involving functions within, the neuromuscular, 
respiratory, phonatory, or articulatory mechanisms” 
(Shapiro, 2011).  
Table 1 outlines the steps of EBP as proposed by 
Law (2002) and used as the methodological 
framework for Bulgarian research projects con-
ducted between 2009 and 2019 at the SWU Stut-
tering Research Center.  
Table 1 
Steps Toward Evidence-Based SLP Practice as Accepted in the USA and Canada 
Step 1 The SLP formulates a specific question about the treatment method to be used in caring for a 
person who stutters 
Step 2 The SLP finds the available published evidence, as available from: 
ASHA’s National Center for Treatment Effectiveness in Communication Disorders  
Treatment Efficacy Bibliographies 
Combined Health Information Database 
ERIC 
Ingenta 
PubMed 
Cochrane Oxford Library (UK) 
Research Navigator 
The Dome 
Evidence-Based Practice Centers (USA and Canada) 
Journal of Speech and Hearing Research (JSHR) special issue series 1996–1998 
Journal of Fluency Disorders (2003) special issue on EBP in stuttering 
Step 3 The SLP evaluates the quality of the evidence obtained at step 2 
Step 4 The SLP makes a reasonable decision about what approach/method to use in caring about the 
patient with stuttering disorder, based in large part on the evidence identified at step 3 
Step 5 The SLP evaluates the impacts and outcomes of the care provided to the client 
 
 
Table 2 outlines the four “levels of evidence” as 
advanced by the Agency for Healthcare Research 
and Quality (AHRQ) of the USA’s Department of 
Health and Human Services. In Bulgaria, as well as 
in the USA and Canada, the application of the 
evidence grading system to stuttering is divided 
into the main categories of developmental 
stuttering in children and stuttering in adults. 
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 Table2  
Levels of Evidence Used to Assess the Strength of Research Findings 
Level of evidence Research Study Design 
Level 1 Randomised controlled trials 
Level 2 Nonrandomised controlled trials 
Level 3 Observational studies with controls 
Level 4 Observational studies without controls 
 
The use of systematic reviews and meta-analyses is 
crucial to the five steps of EBP, especially given the 
wide range of methodologies employed across the 
profession of the SLP, even within stuttering. The 
research challenge in Bulgaria largely centres on 
the ability to select the appropriate methodology for 
the correct assessment and treatment. Similar to 
other health specialties, the variability between 
individuals with fluency disorders guarantees that 
the process of selecting an appropriate research 
methodology will not be straightforward. The 
variety of arguments regarding what constitutes 
valid and reliable research and what may serve as 
trustworthy evidence only adds to the complexity 
(Lowis, Harrison, & Wiland, 2019; O’Connor & 
Pettigrew, 2009). Especially in Bulgaria, the area of 
stuttering disorder, within the profession of the SLP 
is in his infancy with regard to research evidence.  
In general, issues surrounding levels of evidence 
and the application of evidence to clinical decision 
making are problematic for Bulgarian logopedists 
who received their training before or during the 
recent professional shift from a special education 
subspecialty to a health profession specialty as 
represented by speech-language pathology (SLP).  
5. Discussion 
Refining the results with the search term “stutter-
ing” limited to the timeframe of 1980–2015 result-
ed in 13 systematic reviews and meta-analyses. 
ASHA and others have recommended employing 
six or more meta-analyses to support a scientific 
evidence base for clinical practice, particularly for 
AWS (Baxter et al., 2016; Franic, & Bothe, 2008; 
Herder, Howard, Nye, & Vanryckeghem, 2006; 
Pertijs et al., 2014). 
There is also controversy as to which measure-
ments are the most useful and reliable in practice. 
Bothe, Davidow, Bramlett, and Ingham (2006) 
reviewed 162 articles resulting in 197 units of 
analysis, as some articles contained comparisons 
and, therefore, analyses of more than one treatment. 
Of these, 39 met the required four out of five trial-
quality criteria for inclusion as research based. All 
of them measured stuttering frequency as well as 
social, emotional, or cognitive (SEC) measures. 
The maintenance of reduced stuttering or impro-
vement on SEC measures at least 6 months post-
treatment was analysed by the author.  
The different methods for measurement of the 
stuttering treatment outcomes in children and adults 
are recommended to be used as effectiveness in-
struments: Stuttering, S-24 (Andrews & Cutler, 
1974); The Stuttering Self-Rating of Reactions to 
Speech Situations (Darley and Spriesterbach, 
1978); The A-19 Scale for Children who Stutter 
(Guitar and Grimes, 1977); The Stuttering Severity 
Instrument SSI-4 (elaborated by Riley, 2009); The 
Kiddy CAT Communication Attitude Test Pre-
school-kindergarten (Vanryckeghem & Brutten, 
2007); The Wright and Ayer Stuttering Self-Rating 
Profile (WASSP, Ayre & Wright, 2009; Wright & 
Ayre, 2000), and The Overall Assessment of the 
Speaker’s Experience of Stuttering (OASES, 
Yaruss & Quesal, 2004). 
The treatment of persons who stutter has been a 
subject of discussion for many years in the field of 
communication sciences and disorders. According 
to the Law (2007) the data retrieved from 1788 
articles (of which only 19 met the inclusion criteria) 
show that there is no single treatment approach for 
stuttering. In Bulgaria, the USA, and Canada, the 
fluency shaping approach has been commonly 
preferred for both children and adults who stutter. 
One of the reasons for application is the fact that all 
Georgieva, D., Orlikoff, R. F.                             Overview of Evidence-Based Treatment of Stuttering in Bulgaria and in the USA and Canada  
__________________________________________________________________________________________
124                                                                                                                                                 https://jrtdd.com 
 
fluency shaping programs measure changes in the 
level of stuttering. 
Empirical investigations of treatment for AWS 
have focused primarily on the fluency shaping and 
stuttering modification approaches. Fluency shap-
ing is aimed at speech restructuring by introducing 
new and modified speech patterns and reinforcing 
fluency (e.g. Howie & Woods, 1982; Onslow, 
Costa, Andrews, Harrison, & Packman, 1996; 
Onslow, Menzies, & Packman, 2001; Packman, 
Onslow, & van Doorn, 1994). Conversely, stutter-
ing modification addresses not only managing 
fluency, but also the impact of stuttering on the 
individual, as well as the negative perceptions and 
feelings associated with stuttering (e.g. Blomgren et 
al., 2005; Yaruss, 2001; Yaruss, Coleman, & 
Hammer, 2006). Nonetheless, efficacy data on 
these treatment approaches remains limited (Bothe 
et al., 2006).  
Although there is a long history of the stuttering 
modification approach in the USA and Canada, it 
has only been recently applied in Bulgarian clinical 
research practice and outcomes data after 3-year 
intensive treatment (IT) have been reported 
(Georgieva, 2014). Van Riper’s non-avoidance 
approach (intensive group therapy) was applied in 
Bulgaria (2010-2014) with fifteen AWS between 
22 and 28 years of age (mean = 25.2 years). They 
were enrolled in a 5-day IT program with a stabili-
sation phase after 9 months of IT. Follow-up data 
regarding the overall effect were collected over a 3-
year period. The duration of disfluencies (DDs) in 
seconds and the index of disfluences (ID) were 
measured. Data showed positive results and signif-
icant reduction of DDs immediately following and 
3 years after the IT (p < .184). The overall effect 
indicates significant fluency changes (p < .001) of 
ID after IT and after 3 years (Georgieva, 2015a; 
Georgieva, 2015b; Georgieva, Simonska, Stoilova, 
2019, p. 253). The results represent only the initial 
step in evaluating the outcomes obtained by inten-
sive group therapy for AWS in Bulgaria.  
To meet international standards, an evidence-based 
integrated therapy model for stuttering therapy was 
instituted. A meta-analysis of stuttering publica-
tions indicated that the Lidcombe program pro-
gram was among the most effective treatment 
methods (Onslow, Packman, & Harrison, 2003; 
Block, Onslow, Packman, Gray, Dacakis, 2005). 
The Lidcombe program accordingly was applied 
for early stuttering treatment in Bulgaria between 
2010 and 2014. Sixteen children who stutter be-
tween the ages of 2 to 7 years (3:1 male/female 
ratio) were selected in for study. Measurement 
procedures consisted of the disfluency index (DI) 
and the number of syllables stuttered per minute 
(SSm). No significant difference regarding correla-
tion of intervention progress and stuttering severity 
was found (p > 0.05). Nonetheless, the results 
showed a significant difference between initial and 
final part the Stage 1 regarding the DI and SSm (p 
< 0.001). A significant difference between initial 
part of the study and three years after the therapy 
was found (p < 0.001), (Georgieva, Simonska, & 
Stoilova, 2019, p. 254). In conclusion, the results 
suggest that by implementing Lidcombe program 
positive results can be obtained early in stuttering 
treatment. 
An overview of SMAs indicate that prolonged 
speech and gentle onset are the most effective tech-
niques in short and long terms periods than either 
attitude or airflow techniques (Andrews, Guitar, & 
Howie, 1980). Georgieva and her colleagues 
(Georgieva, Stoilova, & Tcholakova, 2016; 
Georgieva & Stoilova, 2018; Georgieva, 
Simonska, & Stoilova, 2019) also studied the ap-
plication of the La Trobe prolonged speech pro-
gram between 2015 and 2018 for ten males and 
two female AWS (ages 18 to 29; mean = 22.4 
years). Percent stuttered syllables (%SS) and natu-
raleness (NA) were measured. The percentage SS 
reduction tendency was maintained also 1 day 
before the IT and 36 months after the IT: mono-
logue outside clinic (Z = 3.069; p < 0.01), conversa-
tion outside clinic (Z = 3. 064; p < 0.01) telephone-
home (Z = 3.063; p < 0.01), and conversation-
home (Z = 3.063; p < 0.01). The mean NA score 
was 6 at pre-treatment, 1.58 immediately after the 
IT, and 2.4 36 months after the IT. The Friedman 
analysis (p = 0.024) showed significant changes (p 
< 0.05). The Wilcoxon signed rank test results also 
indicated the same trend 36 months after the IT (p 
< 0.011), (Georgieva, Simonska, & Stoilova, 2019, 
p. 254-255). They concluded that, by implement-
ing La Trobe prolonged speech program, positive 
results were obtained immediately and 3 years after 
the stuttering treatment. 
In Bulgaria as well as in Canada and the USA, the 
assessment of lifestyle needs took place in the con-
text of the WHO ICF model (2001) developed for 
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stuttering by Yaruss and Quesal (2004, 2006). This 
internationally recognised model was a general 
framework for the cited studies above and was 
providing the impetus for identifying activities and 
social roles appropriate for individuals with stutter-
ing as a main goal of therapy process. 
6. Conclusion 
The professional bodies that govern clinical prac-
tice in the Bulgarian health fields are not currently 
guided by EBP concepts. There are no established 
guidelines based on existing SLP practice which, in 
itself, is not well documented. Further, the term 
logopedist (or speech-language pathologist) is not 
a protected title in Bulgaria and there is no regula-
tion of clinical practice. There is no evidence-based 
framework for the prevention, diagnosis, and 
treatment of stuttering as there is in the USA and 
Canada, which follow the revised guidelines for 
initial education in speech-language pathologyas 
established by the International Association of 
Logopedics and Phoniatrics (IALP; Cheng, 2010).   
In Bulgaria there is a positive accumulated experi-
ence in some state universities because the IALP 
guidelines provide relevant information on the 
education and training of SLPs. The illustrative 
framework states that students should receive train-
ing in fluency disorders (stuttering). Following the 
research-based teaching model at university level, 
the Master’s degree curriculum in SLP has been 
revised to include a new course in 2015, EBP in 
SLP.   
There is no doubt that the application of EBP in 
SLP in Bulgaria will increase the quality of the 
scientific and experimental research on stuttering; 
will provide the necessary additional high-tech 
equipment for appropriate research; will offer high-
quality assessment and therapy for clients with a 
stuttering disorder on a national level, and will 
improve the quality of life of the clients with severe 
fluency disorders and provide them with an 
appropriate social integration. The creation of new 
clinical pathways for persons with fluency 
disorders outside of non hospital clinics is a real and 
ongoing challenge for Bulgarian practitioners.  
EBP stands as a fundamental way to promote 
changes appropriate for a health profession, and 
can be applied to: (i) students training in SLP at the 
university level; (ii) conduct of high-quality re-
search studies; and (iii) be an effective clinical ap-
plication of evidence-based assessment and treat-
ment regarding different aged groups of clients 
with a stuttering disorder.  
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